Today, research on the effects of psychedelics is one of the most exciting fields of psychology. The US Food and Drug Administration recently approved a clinical trial to test if the psychedelic compound in ecstasy can treat PTSD; psilocybin, the key ingredient in magic mushrooms is now considered a promising treatment for depression; and studies suggest that LSD could help combat alcoholism. Theres still plenty of red tape and skepticism, but it feels like scientists are well on their way to establishing the health benefits of these powerful drugs.
It feels terribly cutting edge, but such research is, in fact, old. Before LSD became a party drug, it was used to treat conditions like alcoholism, PTSD, and depression. And, as a new documentary on Cary Grant explores, the actor was one of the first to experience LSD in a psychiatric setting.
According to the film, Becoming Cary Grant, the actor first tried LSD at the Psychiatric Institute of Beverly Hills in 1958 and took the drug 100 times over the following three years. He was effusive about the results, as Vanity Fair reports, telling Look magazine in 1959, at last, I am close to happiness. He viewed the treatment as a way of resolving childhood trauma and coming to terms with the ends of difficult marriages; after starting his LSD treatment, Grant realized, all my life, Ive been going around in a fog.
Though LSD had been used as treatment for a few years previously, Grants enthusiasm helped popularize the then-little-known drug. In total, from 1950-1965, around 40,000 patients were prescribed LSD to treat a variety of conditions. The drug was little known at first but gradually increased in popularity before US drug safety regulations began to restrict its use in 1962. In 1966, possession of the drug was made illegal in the US.
The backlash against LSDpartly attributed to negative experiences of the drug, or bad trips, and partly to its association with the political counterculture of the timewas closely linked not just to its recreational use, but also the lack of rigor around psychological research at the time. Timothy Leary, a Harvard psychologist who was studying the psychological effects of psychedelics in the late 1950s and early 1960s, was not allowed to continue working at the university in 1963, in part due to his sloppy research. Leary was accused of giving psychedelics to undergraduates without medical supervision and, after leaving academia, went on to promote psychedelics with the phrase, Turn on, tune in, drop out. Then-president Richard Nixon reportedly called him the most dangerous man in America.
But though early research in LSD as therapy has a decidedly mixed reputation, Robin Carhart-Harris, head of Psychedelic Research at Imperial College London, says that much of the work undertaken in the 1950s and 60s was actually quite strong.
Its easy for us to be derogatory about the old research but they were asking all the questions were asking now, he says, Perhaps the methods werent as tight as they are today but, even so, there was a fair amount of good work.
Today, he says researchers are more privileged. Brain imaging has been instrumental in navigating the effects of psychedelics and there are now standard rating scales for measuring depression, for example, as well as careful placebo control procedures and a greater awareness of biases.
Carhart-Harris says he and his colleagues occasionally read through older literature. It can feel reassuring, he says, to see that the effects theyre finding today were also noted decades ago.
In a way were re-inventing the wheel, but were doing it with the knowledge and methods we have now, he says. You can think of the old literature as being quite extensive and rich but also a little loose and quite poetic.
Herbert Kleber, professor of psychiatry and substance-abuse researcher at Columbia University, notes that the smaller doses used today are far safer than in previous decades. While working on narcotics addiction at the US Public Health Service Hospital in Lexington, Kentucky (now called the Federal Medical Center) in 1965, Kleber conducted research into LSDs potential as a treatment treatment for addiction.
He did not get far in his research, and though he believed there were early signs that the drug could be useful for breaking addiction cycles, he also saw plenty of bad trips. I remember there was a painting on the wall and under the influence of LSD, one patient [in the study] saw the painting come off the wall and chase him around the room, he says. Another one tried to break down a door because he was convinced his wife was on the other side and we were keeping her from him. Kleber was interested in testing the drug at a lower dose, he says, but LSD was banned soon after.
Despite the downsides, researchers were uncovering the potential value of LSD. Carhart-Harris points out that prominent figures such as senator Robert F. Kennedy were supportive of the research, and went to bat for LSD in Washington, DC. If they [LSD experiments] were worthwhile six months ago, why arent they worthwhile now? Kennedy asked the FDA in 1966, after research on the drug was banned. Perhaps to some extent we have lost sight of the fact that [LSD] can be very, very helpful in our society if used properly.
But research into the medical benefits of psychedelics stalled in the late 1960s. [Cultural attitudes] are very powerful and they stick, says Carhart-Harris. Were the victims of that, and so are patients to some extentvictims of this stigma and misinformation. As a result, there are no approved medicinal uses for LSD, but both Kleber and Carhart-Harris agree theres evidence the research should continue. If you have a compound that seems to be beneficial, works in a novel way, and does something different than currently available treatments, then you could really question the ethics of withholding funding, says Carhart-Harris.
The good news is that, thanks in part to tighter research methods, government agencies are starting to loosen up restrictions on studying psychedelics. Psychologists are now picking up a decades old experiment. Were both catching up and advancing, adds Carhart-Harris.
But theres no guarantee that the trend will hold. I dont want to be too naive and say, its just not going to happen this time because weve learnt from the mistakes of the past, says Carhart-Harris. After all, he adds, in politics, anything can happen.
See the original post here:
- Key Insights from PSYCH: The Psychedelics as Medicine Report - Prohibition Partners - March 18th, 2020
- Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week - Benzinga - March 18th, 2020
- With No Progress in Therapy, NYC Couple Turns to Psychedelics for Help - NBC New York - March 13th, 2020
- Upscale Psychedelics Therapy Center Opens On New Yorks 5th Avenue - Forbes - March 13th, 2020
- Why Kevin O'Leary is betting on psychedelics - Wealth Professional - March 13th, 2020
- Learning the hard way that psychedelic drug use can have long-term consequences - Dailyuw - March 13th, 2020
- Forget taking a pill a day. Canada is using psychedelics to revolutionize the way we treat mental health and addiction - The GrowthOp - March 13th, 2020
- High Stakes: Will The Legalization Of Psychedelics Mimic That Of Cannabis? Will It Learn From Its Mistakes? - Benzinga - March 13th, 2020
- Scientists Just Proved These Two Brain Networks Are Key to Consciousness - Singularity Hub - March 13th, 2020
- Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week - MarketWatch - March 13th, 2020
- Podcast Host Joe Rogan Is Steadily Documenting A Psychedelic Record Of The 21st Century - Forbes - February 27th, 2020
- Empower Clinics to create psilocybin and psychadelics division leveraging corporate wellness and franchise clinic network - Proactive Investors USA... - February 27th, 2020
- The Psilocybin Movement Is Like The Cannabis Movement (Except When It's Not) - Benzinga - February 27th, 2020
- Researchers went to festivals to study psychedelic drugs and found they left people feeling happy and connected hours after the high wore off -... - January 22nd, 2020
- Psychedelics and Their 'Mystical Effects' in the Real World - Medscape - January 22nd, 2020
- Psychedelic Events Are Going Mainstream, Where The Much-Maligned Mushroom Industry Focuses On Mental Health - Forbes - January 18th, 2020
- Psychedelics have 'extraordinarily potent' anti-inflammatory power. Is there a place for them in mainstream medicine? - Genetic Literacy Project - January 18th, 2020
- Silicon Valley Is Micro-Dosing Magic Mushrooms To Boost Their Careers - Forbes - January 18th, 2020
- NYC To Host Economics Of Psychedelics Investing Summit - Benzinga - January 18th, 2020
- The Best FREE Things to Do for the Next Week - My New Orleans - January 18th, 2020
- Photos of the Stuff That Fascinates People While They're Tripping On LSD - VICE - January 18th, 2020
- Rats on DMT hint at the benefits of psychedelic microdosing - Inverse - December 31st, 2019
- BEYOND LOCAL: Would you ever consider psychedelics to treat PTSD? - SooToday.com - December 31st, 2019
- A Trailblazer of Global Consciousness: Ram Dass Led the Way - Psychology Today - December 31st, 2019
- The Psychedelic Renaissance and the importance of drug policy reform - Open Access Government - December 13th, 2019
- Magic Mushrooms Move Closer to Mainstream Medicine As VC-Backed Compass Touts Safety, Positive Mood Alteration - Karma - December 13th, 2019
- Miami Clinics Use Ketamine IV Therapy to Help Treat Depression and PTSD - Miami New Times - December 13th, 2019
- Andy Frasco Talks Finding Emotional Balance With Psychedelics On 'Psychedelics Today' Podcast [Listen] - Live for Live Music - November 30th, 2019
- Will psychedelics be available commonly in the near future? - BPhrm Dv - November 30th, 2019
- Letters to the Editor: Psychedelics on their way - Valley Advocate - November 30th, 2019
- Scientists Have a Fascinating New Map of the Human Brain on DMT - VICE - November 30th, 2019
- Hes a fungi: U.S. health agency asks researcher to give it the lowdown on psilocybin mushrooms - The GrowthOp - November 30th, 2019
- A Magic Mushroom Test Case, and the Man Behind It - OZY - November 30th, 2019
- The Two Black Women Helping To Reclaim & Encourage Natural Psychedelics Use In Oakland - Okayplayer - November 2nd, 2019
- Molecule Catalyst and UTM to crowdfund psychedelics research with blockchain - Decrypt - November 2nd, 2019
- On writing: What illuminates a story? - Big Think - November 2nd, 2019
- The future of psychedelic science - Varsity - October 20th, 2019
- Psychedelic Drugs: Researchers experimenting with active agent in magic mushrooms to treat addiction, depression and anxiety - 60 Minutes - CBS News - October 17th, 2019
- Investors hope psychedelics are the new cannabis. Are they high? - The Economist - October 17th, 2019
- Mind Trip: Psychedelics Fighting Depression, Anxiety, Addiction - The National Herald - October 17th, 2019
- Devon Welsh on Growing a Mustache, Psychedelics, and Other Complicated Things - Interview - October 17th, 2019
- Roland Griffiths: 5 Fast Facts You Need to Know - Heavy.com - October 17th, 2019
- How Mushrooms Became Magic - The Atlantic - August 25th, 2017
- Using Mushrooms and LSD to Enhance Creativity - How to Use ... - August 20th, 2017
- LSD - Psychedelics - August 16th, 2017
- This Philosopher Thinks Psychedelic Drugs Lead to the Truth of Experience - Big Think - August 16th, 2017
- Can Psychedelics Treat Bipolar Disorder? - August 13th, 2017
- The foundation of Western philosophy is probably rooted in psychedelics - Quartz - August 13th, 2017
- Psychedelic drugs saved my life. So why aren't they prescribed? - Wired.co.uk - August 8th, 2017
- Daniel Greig, Canadian Drug Policy, Responsibilities, and Psychedelics - The Good Men Project (blog) - August 6th, 2017
- THE FUTURE OF PSYCHEDELICS: Are LSD and Mushrooms The New Prozac? - Dope Magazine - August 5th, 2017
- Gonzo Nieto, Drug Policy, Medical and Psychological Effects - The Good Men Project (blog) - August 3rd, 2017
- For children, it's beyond psychedelics - The Hans India - The Hans India - August 1st, 2017
- Modern psychedelic science is reviving lost research and finding new cures - The Plaid Zebra (blog) - August 1st, 2017
- Expanding consciousness - 48 Hills - August 1st, 2017
- What Has Awe Done for Me Lately? - HuffPost - July 31st, 2017
- New book about psychedelics and weird human experiences - Boing Boing - July 26th, 2017
- Psychedelics and Normality - HuffPost - July 26th, 2017
- Reasons to Consider Trying Psychedelics - FoxWeekly - July 25th, 2017
- Psychedelic Shine takes a trip to the skies in Boulder - Boulder Daily Camera - July 22nd, 2017
- Psychedelic drugs could tackle depression in a way that antidepressants can't - INSIDER - July 22nd, 2017
- Do You Take Drugs at Festivals? This Initiative is Working on Keeping You Safe - PoliticalCritique.org - July 20th, 2017
- Should We Reclassify Marijuana as a Hallucinogen? - Big Think - July 20th, 2017
- Countdown To (Legalized) Ecstasy! Rick Doblin, MAPS, & the Psychedelic Renaissance [Podcast] - Reason (blog) - July 20th, 2017
- Can Psychedelics Be Therapy? Allow Research to Find Out - New York Times - July 18th, 2017
- Psychiatrists Say Cannabis Medicine Has Psychedelic Properties - The Marijuana Times - July 15th, 2017
- Are psychedelics the new medical marijuana? - WTSP 10 News - July 13th, 2017
- Alameda author's new book examines psychedelic drugs' medical use - East Bay Times - July 12th, 2017
- Do Psychedelic Drugs Cause the 'Prophetic Effect'? - Breaking Israel ... - Breaking Israel News - July 11th, 2017
- Shrooms Could Be Legalized Sooner Than You Think - VICE - July 11th, 2017
- Parliament George and the Psychedelics? Mayor gets playful lesson on hipness - The Telegraph (blog) - July 8th, 2017
- About Us | Trusted News Source for Psychedelic Research ... - July 7th, 2017
- My grandfather was a death row doctor. He tested psychedelic drugs on Texas inmates. - Texas Tribune - July 5th, 2017
- Psychedelics Could Help Asia's Mental Health Care, But Stigma Remains Roadblock - TheFix.com - July 4th, 2017
- Is LSD the new coffee? - FactorDaily - July 4th, 2017
- Tune in, Turn on, Stay in School - Study Breaks - July 2nd, 2017
- The brain on DMT: mapping the psychedelic drug's effects - Wired.co.uk - July 2nd, 2017
- Cannabist Show: He's psychedelic comedian Shane Mauss - The Cannabist - July 1st, 2017
- The war on drugs is back. Will psychedelic drug research survive? - The Verge - June 29th, 2017
- Psychedelics and Virtual Reality Make a Trendy but Illegal Therapy - Inverse - June 27th, 2017